AtenololAntihypertensive AgentsSodium Chloride Symporter InhibitorsHypertensionDiureticsBenzothiadiazinesBendroflumethiazideThiazidesBlood PressureAdrenergic beta-AntagonistsHydrochlorothiazideMetolazoneMethyldopaChlorthalidoneAmlodipineCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsTrichlormethiazidePropanolaminesHydralazineDoxazosinDrug Therapy, CombinationIndapamideAngiotensin II Type 1 Receptor BlockersBlood Pressure Monitoring, AmbulatoryNifedipineBlood Pressure DeterminationLisinoprilChlorothiazideRats, Inbred SHRPropranololDouble-Blind MethodCaptoprilHypokalemiaHeart RateEnalaprilTetrazolesDihydropyridinesMetoprololClinical Trials as TopicMethyclothiazideTreatment OutcomeAcebutololGuanabenzAngiotensin Receptor AntagonistsClonidineTriamtereneHypertension, RenalLosartanPulseRisk FactorsReninDrug PrescriptionsAdrenergic beta-1 Receptor AntagonistsPatient ComplianceBenzimidazolesHypertrophy, Left VentricularAdrenergic alpha-AntagonistsSystolePerindoprilKidneyFollow-Up StudiesPhysician's Practice PatternsTime FactorsSpironolactoneBisoprololLabetalolMinoxidilDihydralazineProspective StudiesDrug UtilizationNordefrinDrug CombinationsRandom AllocationNitrendipineDose-Response Relationship, DrugRenin-Angiotensin SystemPrazosinGitelman SyndromeCardiovascular DiseasesDrug InteractionsBiphenyl CompoundsRats, Inbred WKYMedication AdherenceUric AcidKidney Failure, ChronicPindololHypertension, MalignantHypertension, RenovascularAldosteronePlacebosReserpineCeliprololHemodynamicsReceptors, DrugPregnancy Complications, CardiovascularRandomized Controlled Trials as TopicDrug CostsFurosemideValine